Roche Diagnostics North America CEO Succession Takes Effect

Dan Malarek becomes President and CEO of Roche Diagnostics North America, succeeding the retiring Brad Moore, as Roche also creates a new U.S. Chief Commercial Officer role and names an interim CEO at Foundation Medicine.

Company: Roche Diagnostics · Event Type: Leadership Transition · Role: President and CEO, Roche Diagnostics North America · Incoming: Dan Malarek · Outgoing: Brad Moore · Effective Date: August 1, 2026 Summary Roche appointed Dan Malarek President and CEO of Roche Diagnostics North America, succeeding…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

Pfizer – SF R&D Site Closure
Tempus Acquires Personalis for $1.5 Billion
Waypoint Bio – China IIT CAR-T Strategy
J&J Completes Firefly Bio Acquisition